HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kimberly A Robell Selected Research

ON012380

2/2005A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kimberly A Robell Research Topics

Disease

4Neoplasms (Cancer)
09/2011 - 01/2008
1Breast Neoplasms (Breast Cancer)
09/2011
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2005
1Leukemia
02/2005
1Philadelphia Chromosome
02/2005

Drug/Important Bio-Agent (IBA)

2Glycogen Synthase Kinase 3 betaIBA
01/2010 - 01/2010
1Antineoplastic Agents (Antineoplastics)IBA
09/2011
1Cyclin DIBA
09/2011
1ON 01910IBA
09/2011
1Acetates (Acetic Acid Esters)FDA Link
09/2011
1Proteins (Proteins, Gene)FDA Link
09/2011
1SodiumIBA
09/2011
1IndazolesIBA
01/2010
1Phosphotransferases (Kinase)IBA
01/2010
1Pharmaceutical PreparationsIBA
01/2010
1ON012380IBA
02/2005
1Imatinib Mesylate (Gleevec)FDA Link
02/2005
1bcr-abl Fusion ProteinsIBA
02/2005
1Protein Isoforms (Isoforms)IBA
02/2005

Therapy/Procedure

2Therapeutics
09/2011 - 01/2008